Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

Therapy response in AML: a tale of two T cells

Livius Penter, Catherine J. Wu

Blood (2024) 144 (11): 1134–1136.

https://doi.org/10.1182/blood.2024024593

Published: 2024

Journal Articles

Leukemia Blasts Induce NK-like Dysfunction in AML-Specific T Cells

Francesco Mazziotta, Lauren E Martin, Miranda Lahman, Daniel N. Egan, Sinéad Kinsella, Kelly Paulson, Yapeng Su, Valentin Voillet, Livius Penter, Catherine J Wu, Philip Greenberg, Aude G Chapuis

Blood (2023) 142 (Supplement 1): 4849.

https://doi.org/10.1182/blood-2023-189773

Published: 2023

Journal Articles

An Analytic Framework for the Prediction of Gvl Minor Histocompatibility Antigens to Prevent or Treat Post-Transplant Relapse

Blood (2023) 142 (Supplement 1): 361.

https://doi.org/10.1182/blood-2023-187705

Published: 2023

Journal Articles

Coordinated Immune Cell Networks in the Bone Marrow Microenvironment Define the Graft Versus Leukemia Response with Adoptive Cellular Therapy

Alexandria Maurer, Cameron Y Park, Shouvik Mani, Mehdi Borji, Crystal Shin, Livius Penter, James R Brenner, Jackson Southard, Wesley S Lu, Haoxiang Lyu, Shuqiang Li, Kenneth J. Livak, Jerome Ritz, Robert J. Soiffer, Elham Azizi, Catherine J Wu

Blood (2023) 142 (Supplement 1): 363.

https://doi.org/10.1182/blood-2023-189292

Published: 2023

Journal Articles

Integrative Single-Cell Tracking of Clonal Evolution, Leukemia Phenotypes and Donor Engraftment Following Allogeneic Stem Cell Transplant Using Mitochondrial DNA Mutations

Livius Penter, Nicoletta Cieri, Katie Maurer, Haoxiang Lyu, Wesley S Lu, Giacomo Oliveira, Satyen H Gohil, Caleb Lareau, Leif S Ludwig, Shuqiang Li, Jerome Ritz, Jacqueline S. Garcia, Robert J. Soiffer, Kenneth J. Livak, Catherine J Wu

Blood (2023) 142 (Supplement 1): 3580.

https://doi.org/10.1182/blood-2023-180113

Published: 2023

Journal Articles

Tracking of Leukemia and Immune Single Cell Phenotypes during Ipilimumab-Based Treatment By Long-Read Sequencing

Livius Penter, Mehdi Borji, Adi Nagler, Haoxiang Lyu, Wesley S Lu, Nicoletta Cieri, Alexandria Maurer, Giacomo Oliveira, Aziz M. Al'Khafaji, Kiran Garimella, Shuqiang Li, Donna S. Neuberg, Jerome Ritz, Robert J. Soiffer, Jacqueline S. Garcia, Kenneth J. Livak, Catherine J Wu

Blood (2023) 142 (Supplement 1): 1596.

https://doi.org/10.1182/blood-2023-180016

Published: 2023

Journal Articles

Systematic Prediction of Minor Histocompatibility Antigens to Inform GvHD Outcomes after Allogeneic Stem Cell Transplantation

Blood (2023) 142 (Supplement 1): 652.

https://doi.org/10.1182/blood-2023-187451

Published: 2023

Journal Articles

Ipilimumab plus decitabine for patients with MDS or AML in posttransplant or transplant-naïve settings

Blood (2023) 141 (15): 1884–1888.

https://doi.org/10.1182/blood.2022017686

Published: 2023

Includes: Supplemental data

Journal Articles

Mechanisms of response and resistance to combined decitabine and ipilimumab for advanced myeloid disease

Blood (2023) 141 (15): 1817–1830.

https://doi.org/10.1182/blood.2022018246

Published: 2023

Includes: Supplemental data

Journal Articles

Mechanisms of Response and Resistance to Combination Decitabine and Ipilimumab for Transplant Naïve and Post-Transplant AML/MDS

Blood (2022) 140 (Supplement 1): 10198–10199.

https://doi.org/10.1182/blood-2022-157339

Published: 2022

Journal Articles

Systematic Identification of Autosomal and Y-Encoded Minor Histocompatibility Antigens Reveals Predictors of Chronic Gvhd and Candidate GVL Targets

Blood (2022) 140 (Supplement 1): 4762–4764.

https://doi.org/10.1182/blood-2022-162841

Published: 2022

Journal Articles

AML relapse after a TIGIT race

Livius Penter, Catherine J. Wu

Blood (2022) 140 (11): 1189–1191.

https://doi.org/10.1182/blood.2022017614

Published: 2022

Journal Articles

Dissecting Richter's Syndrome in a Multiplexed CRISPR-Based Mouse Model Reveals Key Changes in MYC, Interferon and BCR Signaling Underlying Transformation

Blood (2021) 138 (Supplement 1): 251.

https://doi.org/10.1182/blood-2021-148614

Published: 2021

Journal Articles

Mitochondrial DNA Mutations Distinguish Individual Donor- and Recipient-Derived Immune Cells Following Matched Unrelated Allogeneic Stem Cell Transplantation

Livius Penter, Jackson Southard, Shuqiang Li, Caleb A. Lareau, Leif S. Ludwig, Nicoletta Cieri, Alexandria Maurer, Daniel J. DeAngelo, Srinika Ranasinghe, Donna S. Neuberg, Vijay G. Sankaran, Robert J. Soiffer, Kenneth J. Livak, Jacqueline S. Garcia, Catherine J. Wu

Blood (2021) 138 (Supplement 1): 1689.

https://doi.org/10.1182/blood-2021-145304

Published: 2021

Journal Articles

Molecular and cellular features of CTLA-4 blockade for relapsed myeloid malignancies after transplantation

Blood (2021) 137 (23): 3212–3217.

https://doi.org/10.1182/blood.2021010867

Published: 2021

Includes: Supplemental data

Journal Articles

Safety and Efficacy of Decitabine Plus Ipilimumab in Relapsed or Refractory MDS/AML in the Post-BMT or Transplant Naïve Settings

Blood (2020) 136 (Supplement 1): 15–17.

https://doi.org/10.1182/blood-2020-136235

Published: 2020

Journal Articles

Clonally Expanded Bone Marrow T Cells Show Effector Differentiation and Rarely Recognize Disease-Associated Antigens in Multiple Myeloma

Carlotta Welters, Meng-Tung Hsu, Christian Alexander Stein, Livius Penter, María Fernanda Lammoglia Cobo, Kerstin Dietze, Eric Blanc, Dieter Beule, Lars Bullinger, MD, Julian Strobel, Holger Hackstein, Armin Gerbitz, MDPhD, Klaus Dornmair, Thomas Blankenstein, Leo Hansmann

Blood (2020) 136 (Supplement 1): 7.

https://doi.org/10.1182/blood-2020-136991

Published: 2020

Journal Articles

Local and Systemic Effects of Immune Checkpoint Blockade on Relapsed Myeloid Malignancies Following Allogeneic Hematopoietic Stem Cell Transplantation

Livius Penter, Yi Zhang, PhD, Alexandra Savell, BS, Srinika Ranasinghe, PhD, Teddy Huang, BS, Nicoletta Cieri, MD PhD, Satyen H Gohil, PhD MB, BS, Wandi Zhang, BS, Shuqiang Li, PhD, Robert Zeiser, PhD, Haesook T. Kim, PhD, Kenneth J. Livak, PhD, Jerome Ritz, MD, Donna S. Neuberg, ScD, Robert J. Soiffer, MD, X. Shirley Liu, PhD, Matthew S. Davids, MD, Pavan Bachireddy, MD, Catherine J. Wu, MD

Blood (2020) 136 (Supplement 1): 34–35.

https://doi.org/10.1182/blood-2020-139487

Published: 2020

Journal Articles

Treatment of Corticosteroid-Refractory Graft-Versus-Host Disease with Ruxolitinib in 95 Patients

Robert Zeiser, MD, Andreas Burchert, MD, Claudia Lengerke, MD, Mareike Verbeek, Kristina Maas-Bauer, MD, Stephan Metzelder, MD, Silvia Spoerl, MD, Markus Ditschkowski, MD, Matyas Ecsedi, MD, Katja Sockel, MD, Francis Ayuk, MD, Salem Ajib, MD, Flore Sicre de Fontbrune, MD, Il-Kang Na, MD, Livius Penter, MD, Udo Holtick, MD PhD, Dominik Wolf, MD, Esther Schuler, MD, Everett Meyer, MD PhD, Petya Apostolova, MD, Hartmut Bertz, MD, Reinhard Marks, Michael Luebbert, MD, Ralph M. Waesch, MD PhD, Christof Scheid, MD PhD, Friedrich Stölzel, MD, Rainer Ordemann, MD, Gesine Bug, MD, Guido Kobbe, MD, Robert Negrin, MD, Mats L Brune, Alexandros Spyridonidis, Annette Schmitt-Graeff, MD, Walter van der Velden, MD, Gerwin Huls, MD PhD, Stephan Mielke, MD, Goetz Ulrich Grigoleit, MD, Jurgen Kuball, MDPhD, Ryan P Flynn, PhD, Gabriele Ihorst, PhD, Jing Du, Bruce R. Blazar, MD, Renate Arnold, MD, Nicolaus Kröger, MD, Joerg Halter, MD, Gerard Socie, Dietrich Beelen, MD, Christian Peschel, MD, Andreas Neubauer, MD, Juergen Finke, MD, Justus Duyster, MD PhD, Nikolas von Bubnoff, MD

Blood (2015) 126 (23): 858.

https://doi.org/10.1182/blood.V126.23.858.858

Published: 2015

NARROW

Therapy response in AML: a tale of two T cells

Leukemia Blasts Induce NK-like Dysfunction in AML-Specific T Cells

An Analytic Framework for the Prediction of Gvl Minor Histocompatibility Antigens to Prevent or Treat Post-Transplant Relapse

Coordinated Immune Cell Networks in the Bone Marrow Microenvironment Define the Graft Versus Leukemia Response with Adoptive Cellular Therapy

Integrative Single-Cell Tracking of Clonal Evolution, Leukemia Phenotypes and Donor Engraftment Following Allogeneic Stem Cell Transplant Using Mitochondrial DNA Mutations

Tracking of Leukemia and Immune Single Cell Phenotypes during Ipilimumab-Based Treatment By Long-Read Sequencing

Systematic Prediction of Minor Histocompatibility Antigens to Inform GvHD Outcomes after Allogeneic Stem Cell Transplantation

Ipilimumab plus decitabine for patients with MDS or AML in posttransplant or transplant-naïve settings

Mechanisms of response and resistance to combined decitabine and ipilimumab for advanced myeloid disease

Mechanisms of Response and Resistance to Combination Decitabine and Ipilimumab for Transplant Naïve and Post-Transplant AML/MDS

Systematic Identification of Autosomal and Y-Encoded Minor Histocompatibility Antigens Reveals Predictors of Chronic Gvhd and Candidate GVL Targets

AML relapse after a TIGIT race

Dissecting Richter's Syndrome in a Multiplexed CRISPR-Based Mouse Model Reveals Key Changes in MYC, Interferon and BCR Signaling Underlying Transformation

Mitochondrial DNA Mutations Distinguish Individual Donor- and Recipient-Derived Immune Cells Following Matched Unrelated Allogeneic Stem Cell Transplantation

Molecular and cellular features of CTLA-4 blockade for relapsed myeloid malignancies after transplantation

Safety and Efficacy of Decitabine Plus Ipilimumab in Relapsed or Refractory MDS/AML in the Post-BMT or Transplant Naïve Settings

Clonally Expanded Bone Marrow T Cells Show Effector Differentiation and Rarely Recognize Disease-Associated Antigens in Multiple Myeloma

Local and Systemic Effects of Immune Checkpoint Blockade on Relapsed Myeloid Malignancies Following Allogeneic Hematopoietic Stem Cell Transplantation

Treatment of Corticosteroid-Refractory Graft-Versus-Host Disease with Ruxolitinib in 95 Patients

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only